December 2025 in “Orvosi Hetilap” Baricitinib is effective and safe for treating alopecia areata.
July 2025 in “Dermatology Practical & Conceptual” Spironolactone is safe for treating hair loss in women without causing low blood pressure.
January 2025 in “International Journal of Gynaecology Research” Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.
August 2024 in “NPI Journal of Science and Technology.” The Golden Retriever's skin condition improved after treatment.
July 2024 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil is generally safe for hypertensive patients with hair loss.
The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.
June 2024 in “Journal of medicinal chemistry” A new AI-driven method shows promise for treating hair loss with a peptide-based drug.
April 2024 in “International journal of reproduction, contraception, obstetrics and gynecology” A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.
February 2024 in “Indian Journal of Postgraduate Dermatology” Senior residency helps dermatology graduates develop skills and plan their careers.
February 2024 in “European heart journal. Case reports” Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.
December 2023 in “Natural product research” Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).
May 2023 in “Accounts of chemical research” New methods can better classify curly hair types and lead to improved hair care products.
September 2022 in “Journal of Sulaimani Medical College” The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.
July 2022 in “المجلة العراقية للصيدلة” Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.
January 2022 in “UiTM Institutional Repositories (Universiti Teknologi MARA)” 2EVCO, enhanced with aloe vera and pandan leaves, promotes faster hair growth and improves skin health.
August 2019 in “Journal of the American Academy of Dermatology” The product effectively improves hair volume in aging individuals.
April 2019 in “C&EN global enterprise” A microneedle patch can help hair regrow.
The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.
The Body Politic both reinforced and challenged traditional masculinity in gay culture.
Topical tretinoin 0.01% cream effectively treats eruptive vellus hair cysts.
January 2015 in “Endocrine updates” Bariatric surgery patients need careful before and after surgery care for safety and long-term health.
November 2014 in “Journal of Cell Biology” Valentina Greco's research shows that the environment around hair follicle stem cells is more crucial for regeneration than the stem cells themselves.
July 2014 in “Hair transplant forum international” The 20th Orlando Live Surgery Workshop was important for the hair restoration field and aimed to influence future surgeons.
May 2012 in “Scientific American” New app improves storm surge predictions; advances in baldness treatment show potential but require time.
December 2011 in “The Diabetes Educator” The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.
October 2011 in “한국생물공학회 학술대회” The shampoo with Scutellaria baicalensis and Glycyrrhiza glabra helps reduce hair loss.
June 2011 in “Journal of clinical and experimental investigations” Oral zinc sulphate is an effective and safe treatment for thallium poisoning.
April 2011 in “Global journal of health science” Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.
December 2007 in “대한피부과학회지” The treatment increased total hair count but wasn't significantly better than placebo.
July 2007 in “Journal of Generic Medicines” The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.